1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Ablation Equipments Overview

3 Products under Development
3.1 Ablation Equipments - Pipeline Products by Stage of Development
3.2 Ablation Equipments - Pipeline Products by Territory
3.3 Ablation Equipments - Pipeline Products by Regulatory Path
3.4 Ablation Equipments - Pipeline Products by Estimated Approval Date
3.5 Ablation Equipments - Ongoing Clinical Trials

4 Ablation Equipments - Pipeline Products under Development by Companies
4.1 Ablation Equipments Companies - Pipeline Products by Stage of Development
4.2 Ablation Equipments - Pipeline Products by Stage of Development

5 Ablation Equipments Companies and Product Overview
5.1 AngioDynamics Inc Company Overview
5.2 Aqua Medical Inc Company Overview
5.3 Asensus Surgical Inc Company Overview
5.4 Avenda Health Inc Company Overview
5.5 Covidien LLC Company Overview
5.6 CPSI Biotech Company Overview
5.7 Creo Medical Ltd Company Overview
5.8 Elesta srl Company Overview
5.9 Endowave Ltd Company Overview
5.10 Eximo Medical Ltd Company Overview
5.11 ExpandoHeat LLC Company Overview
5.12 Fractyl Laboratories Inc Company Overview
5.13 Harmonic Medical Inc Company Overview
5.14 HEPTA Medical SASU Company Overview
5.15 HistoSonics Inc Company Overview
5.16 Hospital for Special Surgery Company Overview
5.17 Ictero Medical Inc Company Overview
5.18 Integra LifeSciences Holdings Corp Company Overview
5.19 Intratherm LLC (Inactive) Company Overview
5.20 Ionix Medical Inc (Inactive) Company Overview
5.21 Massachusetts Institute of Technology Company Overview
5.22 Medtronic Plc Company Overview
5.23 Memorial Sloan Kettering Cancer Center Company Overview
5.24 ProstaCare Pty Ltd Company Overview
5.25 Pulse Biosciences Inc Company Overview
5.26 Sabanci University Nanotechnology Research and Application Center Company Overview
5.27 Southern Illinois University Carbondale Company Overview
5.28 Thermedical Inc Company Overview
5.29 University of California San Francisco Company Overview
5.30 University of Texas at Austin Company Overview
5.31 University of Wisconsin-Stout Company Overview

6 Ablation Equipments- Recent Developments

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables
Ablation Equipments - Pipeline Products by Stage of Development
Ablation Equipments - Pipeline Products by Territory
Ablation Equipments - Pipeline Products by Regulatory Path
Ablation Equipments - Pipeline Products by Estimated Approval Date
Ablation Equipments - Ongoing Clinical Trials
Ablation Equipments Companies - Pipeline Products by Stage of Development
Ablation Equipments - Pipeline Products by Stage of Development
AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Nanoknife System - Bladder Cancer - Product Status
Nanoknife System - Bladder Cancer - Product Description
NanoKnife System - Cervical Cancer - Product Status
NanoKnife System - Cervical Cancer - Product Description
NanoKnife System - Head And Neck Cancer - Product Status
NanoKnife System - Head And Neck Cancer - Product Description
NanoKnife System - Hepatocellular Carcinoma - Product Status
NanoKnife System - Hepatocellular Carcinoma - Product Description
NanoKnife System - Lung Cancer - Product Status
NanoKnife System - Lung Cancer - Product Description
Nanoknife System - Metastatic Lymph Nodes - Product Status
Nanoknife System - Metastatic Lymph Nodes - Product Description
NanoKnife System - Prostate Cancer - Product Status
NanoKnife System - Prostate Cancer - Product Description
NanoKnife System - Rectal Cancer - Product Status
NanoKnife System - Rectal Cancer - Product Description
Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Status
Nanoknife System - Renal Pelvis Urothelial Neoplasms - Product Description
NanoKnife System - Stage III Pancreatic Cancer - Product Status
NanoKnife System - Stage III Pancreatic Cancer - Product Description
Nanoknife System - Stomach Neoplasm - Product Status
Nanoknife System - Stomach Neoplasm - Product Description
POWERWAVE - Product Status
POWERWAVE - Product Description
AngioDynamics Inc - Ongoing Clinical Trials Overview
NanoKnife System - Prostate Cancer - A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in a Low and Intermediate Risk Patient Population
NanoKnife System - Prostate Cancer - Examination of Focal Therapies - MRI-Fusion, HIFU, NanoKnife and Cryotherapy
NanoKnife System - Prostate Cancer - Focal Irreversible Electroporation as Salvage Treatment in Radio-recurrent Prostate Cancer: A Prospective Multicenter Pilot Study
NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer
NanoKnife System - Prostate Cancer - Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue in an Intermediate-risk Patient Population
NanoKnife System - Prostate Cancer - Registry of Irreversible Electroporation for the Ablation of Prostate Cancer with Use of Nanoknife Device; A Multi-center, International Registry to Evaluate the Treatment of Prostate Cancer in Terms of Recurrence, Functional Outcomes and Safety
NanoKnife System - Stage III Pancreatic Cancer - A Randomized, Multicenter, Controlled, Unblinded Study to Assess the Safety and Efficacy of the NanoKnife System for the Ablation of Unresectable Stage 3 Pancreatic Adenocarcinoma
NanoKnife System - Stage III Pancreatic Cancer - Ablation of Unresectable Locally Advanced Pancreatic Cancer with Nanoknife Irreversible Electroporation (IRE) System: Response and Tolerability
NanoKnife System - Stage III Pancreatic Cancer - An Open-label, Multicenter, Prospective Study of Irreversible Electroporation (Nano Knife) Combined with Radiotherapy and Chemotherapy in Patients with Locally Advanced Pancreatic Cancer
NanoKnife System - Stage III Pancreatic Cancer - Assessing Optimal Treatment Settings for the Ablation of Locally Advanced Pancreatic Cancer with CT-guided Percutaneous Irreversible Electroporation (ANTILOPE): A Randomized Feasibility Study
NanoKnife System - Stage III Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
NanoKnife System - Stage III Pancreatic Cancer - Interest of Irreversible Electroporation in the Treatment of Pancreatic Adenocarcinoma
NanoKnife System - Stage III Pancreatic Cancer - IRE: Anti-tumor Immunity Induced by IRE of Unresectable Pancreatic Cancer
NanoKnife System - Stage III Pancreatic Cancer - Irreversible Electroporation for Locally Advanced Pancreatic Ductal Adenocarcinoma (LEAP TRIAL): A Phase I/II Prospective Trial
NanoKnife System - Stage III Pancreatic Cancer - Registry to Evaluate Effectiveness and Safety of the NanoKnife System for the Ablation of Stage 3 Pancreatic Adenocarcinoma
NanoKnife System - Stage III Pancreatic Cancer - Systemic Therapy with a Loco-regional Treatment in Patients with Locally Advanced Pancreatic Cancer: The SMART Study
NanoKnife System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder
NanoKnife System - Hepatocellular Carcinoma - Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
NanoKnife System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE)
NanoKnife System - Hepatocellular Carcinoma - Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial
Nanoknife System - Renal Pelvis Urothelial Neoplasms - Irreversible Electroporation (IRE) for Unresectable Renal Pelvic and Ureteral Neoplasms: Phase I and Phase II Clinical Trial
Nanoknife System - Metastatic Lymph Nodes - Irreversible Electroporation (IRE) for Unresectable Lymph Node Metastases: Phase I and Phase II Clinical Trial
NanoKnife System - Lung Cancer - Irreversible Electroporation (IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency: Phase I and Phase II Clinical Trial
Nanoknife System - Stomach Neoplasm - Irreversible Electroporation (IRE) for Unresectable Stmoach Neoplasms: Phase I and Phase II Clinical Trial
Nanoknife System - Bladder Cancer - Irreversible Electroporation (IRE) for Unresectable Urinary Bladder Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Cervical Cancer - Irreversible Electroporation (IRE) for Unresectable Uterine Cervical Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Rectal Cancer - Irreversible Electroporation (IRE) for Unresectable Rectal Neoplasms: Phase I and Phase II Clinical Trial
NanoKnife System - Head And Neck Cancer - Irreversible Electroporation (IRE) for Unresectable Head and Neck Neoplasms: Phase I and Phase II Clinical Trial
Aqua Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Radio Frequency Vapor Ablation (RFVA) System - Precancerous Pancreatic Cysts - Product Status
Radio Frequency Vapor Ablation (RFVA) System - Precancerous Pancreatic Cysts - Product Description
Radio Frequency Vapor Ablation (RFVA) System - Pulmonary Tissue Ablation - Product Status
Radio Frequency Vapor Ablation (RFVA) System - Pulmonary Tissue Ablation - Product Description
Radio Frequency Vapor Ablation (RFVA) System - Type 2 Diabetes - Product Status
Radio Frequency Vapor Ablation (RFVA) System - Type 2 Diabetes - Product Description
Asensus Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Barrett's Excision Device - Product Status
Barrett's Excision Device - Product Description
Avenda Health Inc Pipeline Products & Ongoing Clinical Trials Overview
Orion System - Product Status
Orion System - Product Description
Avenda Health Inc - Ongoing Clinical Trials Overview
Orion System - Office-based Focal Laser Ablation of Prostate Cancer: An Early Feasibility Study Using MRI/US Image Fusion for Guidance
Covidien LLC Pipeline Products & Ongoing Clinical Trials Overview
Emprint Ablation Catheter Kit - Product Status
Emprint Ablation Catheter Kit - Product Description
CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Pressurized Sub-Cooled Nitrogen System - Product Status
Pressurized Sub-Cooled Nitrogen System - Product Description
Super-Critical Nitrogen (SCN) Cryoablation Device - Product Status
Super-Critical Nitrogen (SCN) Cryoablation Device - Product Description
Creo Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Flexible Ablation System - Product Status
Flexible Ablation System - Product Description
Elesta srl Pipeline Products & Ongoing Clinical Trials Overview
EchoLaser - Product Status
EchoLaser - Product Description
EchoLaser EVO SoracteLite - Product Status
EchoLaser EVO SoracteLite - Product Description
Glossary

List of Figures
Ablation Equipments - Pipeline Products by Stage of Development
Ablation Equipments - Pipeline Products by Territory
Ablation Equipments - Pipeline Products by Regulatory Path
Ablation Equipments - Pipeline Products by Estimated Approval Date

Companies Mentioned
- AngioDynamics Inc
- Aqua Medical Inc
- Asensus Surgical Inc
- Avenda Health Inc
- Covidien LLC
- CPSI Biotech
- Creo Medical Ltd
- Elesta srl
- Endowave Ltd
- Eximo Medical Ltd
- ExpandoHeat LLC
- Fractyl Laboratories Inc
- Harmonic Medical Inc
- HEPTA Medical SASU
- HistoSonics Inc
- Hospital for Special Surgery
- Ictero Medical Inc
- Integra LifeSciences Holdings Corp
- Intratherm LLC (Inactive)
- Ionix Medical Inc (Inactive)
- Massachusetts Institute of Technology
- Medtronic Plc
- Memorial Sloan Kettering Cancer Center
- ProstaCare Pty Ltd
- Pulse Biosciences Inc
- Sabanci University Nanotechnology Research and Application Center
- Southern Illinois University Carbondale
- Thermedical Inc
- University of California San Francisco
- University of Texas at Austin
- University of Wisconsin-Stout